Effect of Hypoglycemia on QT Interval in Individuals With and Without Type 2 Diabetes: A Randomized Crossover Trial
Andrea V Haas1,2, Andrew W Koefoed1, Johanna Celli3
1Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
Background:
Our goal was to determine in healthy individuals and individuals with type 2 diabetes the impact of repeated episodes of hypoglycemia on the corrected QT (QTc) interval and the time course for QTc recovery. Further, since hypoglycemia increases aldosterone and patients with primary aldosteronism have prolonged QTc, we also determined whether mineralocorticoid receptor blockade prevents hypoglycemia-induced QTc alterations.
Methods:
Twenty-seven healthy participants completed a double-blinded crossover trial contrasting 3 experimental conditions: (1) euglycemia, (2) hypoglycemia, and (3) hypoglycemia with mineralocorticoid receptor blockade pretreatment. Sixteen participants with type 2 diabetes completed 1 condition, hypoglycemia. Hyperinsulinemic clamps were performed to induce the hypoglycemic and euglycemic conditions. Electrocardiograms were performed before, during, and after the clamps.
Results:
Healthy participants had a significant (P < .0001) prolongation of QTc during both the morning and afternoon hypoglycemic clamps as compared with euglycemic clamps (morning hypoglycemia vs euglycemia: 439.06 ± 41.18 ms vs 406.96 ± 26.16 ms; afternoon hypoglycemia vs euglycemia: 441.50 ± 34.36 ms vs 407.78 ± 19.18 ms). Mineralocorticoid receptor (MR) blockade did not alter the response to hypoglycemia. Participants with diabetes achieved a significant prolongation of QTc during the afternoon hypoglycemia only (afternoon hypoglycemia vs morning baseline: 461.96 ± 49.14 vs 428.90 ± 28.54, P < .05). In both participant populations, QTc intervals were similar to baseline 90 minutes after return to euglycemia and the following day.
Conclusion:
Hypoglycemia prolonged QTc in healthy participants, and this was not altered by MR blockade. In individuals with type 2 diabetes, 2 hypoglycemic episodes were required to achieve prolongation. Reassuringly, in both study populations, hypoglycemia-induced QTc prolongation resolved quickly with no apparent residual effects the next day.
More Related Videos
06:13Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
Related Concept Videos
Hypoglycemia and Glucagon
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes Mellitus: Type 2 and Gestational
Oral Hypoglycemic Agents: Glinides
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
